LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases.

In addition to our proprietary research, we also develop vaccines together with GSK.

Biotechnology

Life Sciences

Therapeutics

LimmaTech Biologics AG

Franz-Werner Haas

Dr. Franz-Werner Haas

Camilla Petrycer Hansen

Paul Wolfrom

Michael Kowarik

Patricia Martin Killias

Michael Reindl

LimmaTech Biologics AG

Org chart

Teams

Similar companies